- Home
- SGMO vs RMMZ Comparison
SGMO vs RMMZ Comparison
Compare SGMO & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- RMMZ
- Stock Information
- Founded
- SGMO 1995
- RMMZ 2022
- Country
- SGMO United States
- RMMZ United States
- Employees
- SGMO N/A
- RMMZ N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- RMMZ Investment Managers
- Sector
- SGMO Health Care
- RMMZ Finance
- Exchange
- SGMO Nasdaq
- RMMZ Nasdaq
- Market Cap
- SGMO 122.8M
- RMMZ 122.3M
- IPO Year
- SGMO 2000
- RMMZ N/A
- Fundamental
- Price
- SGMO $0.58
- RMMZ $14.24
- Analyst Decision
- SGMO Buy
- RMMZ
- Analyst Count
- SGMO 6
- RMMZ 0
- Target Price
- SGMO $4.50
- RMMZ N/A
- AVG Volume (30 Days)
- SGMO 7.8M
- RMMZ 25.6K
- Earning Date
- SGMO 08-07-2025
- RMMZ 01-01-0001
- Dividend Yield
- SGMO N/A
- RMMZ 7.33%
- EPS Growth
- SGMO N/A
- RMMZ N/A
- EPS
- SGMO N/A
- RMMZ 0.82
- Revenue
- SGMO $81,706,000.00
- RMMZ N/A
- Revenue This Year
- SGMO $1.29
- RMMZ N/A
- Revenue Next Year
- SGMO $1.60
- RMMZ N/A
- P/E Ratio
- SGMO N/A
- RMMZ $19.41
- Revenue Growth
- SGMO 565.52
- RMMZ N/A
- 52 Week Low
- SGMO $0.41
- RMMZ $12.92
- 52 Week High
- SGMO $3.18
- RMMZ $16.99
- Technical
- Relative Strength Index (RSI)
- SGMO 58.57
- RMMZ 58.43
- Support Level
- SGMO $0.50
- RMMZ $14.11
- Resistance Level
- SGMO $0.58
- RMMZ $14.35
- Average True Range (ATR)
- SGMO 0.05
- RMMZ 0.11
- MACD
- SGMO 0.00
- RMMZ 0.03
- Stochastic Oscillator
- SGMO 84.21
- RMMZ 75.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.